Kennerly Patrick to Attention Deficit Disorder with Hyperactivity
This is a "connection" page, showing publications Kennerly Patrick has written about Attention Deficit Disorder with Hyperactivity.
Connection Strength
2.104
-
Drug Regimen Individualization for Attention-Deficit/Hyperactivity Disorder: Guidance for Methylphenidate and Dexmethylphenidate Formulations. Pharmacotherapy. 2019 06; 39(6):677-688.
Score: 0.510
-
The Clinical Pharmacokinetics of Amphetamines Utilized in the Treatment of Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2017 Oct; 27(8):678-689.
Score: 0.470
-
Evolution of stimulants to treat ADHD: transdermal methylphenidate. Hum Psychopharmacol. 2009 Jan; 24(1):1-17.
Score: 0.257
-
Given the multifaceted nature of ADHD, namely its physiologic, cognitive, psychological, and behavioral manifestations, multimodal approaches to treatment are advocated. Introduction. J Clin Psychopharmacol. 2008 Jun; 28(3 Suppl 2):S37-8.
Score: 0.247
-
Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? J Clin Psychopharmacol. 2008 Jun; 28(3 Suppl 2):S54-61.
Score: 0.247
-
New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder. Expert Opin Drug Deliv. 2005 Jan; 2(1):121-43.
Score: 0.195
-
Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations. Pharmacotherapy. 2003 Oct; 23(10):1281-99.
Score: 0.179